Genetics of Parkinsonism in a Special Population of Untreated Schizophrenia
未经治疗的精神分裂症特殊人群中帕金森症的遗传学
基本信息
- 批准号:8032861
- 负责人:
- 金额:$ 16.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-08-01 至 2014-04-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdverse effectsAffectAgeAggressive behaviorAntipsychotic AgentsArgentinaAttentionAttitude to HealthAwardBloodBlood specimenBradykinesiaCharacteristicsClassificationClinicalCognitiveCognitive deficitsCollectionConsentControl GroupsDNADataDatabasesDeltastabDependenceDevelopmentDiagnosisDiagnosticDiamondDimensionsEarly DiagnosisEarly treatmentEnrollmentEpidemiologyEquipment and supply inventoriesFirst Degree RelativeFundingFutureGeneral PopulationGenesGeneticGenetic VariationGenomicsGoalsHealthHealth systemHeritabilityHigh PrevalenceImageImpairmentIndividualInstitutionInterviewLanguageLifeLinkMaster&aposs DegreeMeasuresMemory impairmentMental HealthMental disordersMentorshipMidbrain structureMotorMovementMovement DisordersMultivariate AnalysisMuscle RigidityNeurobiologyNeurocognitiveNeurologicNeurologic ExaminationNeurologistNeurologyNewly DiagnosedNicotineNicotine DependenceNoiseOutcomeParkinson DiseaseParkinsonian DisordersParticipantPathway interactionsPatientsPatternPharmaceutical PreparationsPhenotypePopulationPopulation ControlPredispositionPrevalencePreventionPrincipal InvestigatorProvincePsychiatristPsychiatryPsychotic DisordersQuality of lifeQuantitative Trait LociRecruitment ActivityResearchResearch PersonnelRiskSamplingScanningScheduleSchizophreniaSeveritiesSex EducationShort-Term MemorySiblingsSignal TransductionSingle Nucleotide PolymorphismSmokeSmokerSmokingSubstance AddictionSubstantia nigra structureSurveysSymptomsSyndromeTemperamentTestingTrainingTransportationTremorUltrasonographyUniversitiesVisuospatialWashingtonWorkbasecareercase controlclinical Diagnosiscompliance behaviordeficit syndromedesignendophenotypeexecutive functionfield surveygenetic epidemiologygenome wide association studyimprovedindexingmRNA Expressionmedical schoolsmeetingsmotor impairmentnamed groupneurobiological mechanismneuropsychiatryneuropsychologicalnon-smokeroutreachpatient populationpreventprobandprofessorprogramsprotective effectsmoking prevalencetooltrait
项目摘要
DESCRIPTION (provided by applicant): The candidate is a neurologist/psychiatrist with training in neurobiology, and an assistant professor of psychiatry and neurology at the Washington University School of Medicine (WUStL), a world leading institution in genetics and epidemiology of psychiatric disorders. The candidate's immediate goal is to complete a master's degree in epidemiology and genetics to maximize opportunities afforded by his currently funded research and under the mentorship of Dr. Cloninger and Dr. Goate. His long term goal is to concentrate his research career on the study of the genetic control of the relationship between parkinsonism and schizophrenia. Project. Parkinsonism is highly prevalent in newly diagnosed -untreated- patients with schizophrenia; its presence predicts greater susceptibility to neuroleptic-induced side effects, reduced treatment compliance and poorer outcome. Smoking has a negative association with parkinsonism, whereas hyperechogenicity of the substantia nigra, executive function and working memory deficits, and increased harm avoidance on the temperament and character inventory are all positively associated with motor impairment. These diverse phenotypic manifestations are related to a single neurobiological mechanism, namely decreased dopaminergic function. Studying untreated patients prevents the noise introduced into such phenotypic manifestations by the effects of antipsychotic drugs, and therefore will permit isolation of the genetic signal from environmental noise (represented by treatment). We identified a population with untreated schizophrenia, and collected a pilot sample to study the clinical, neuropsychological and neurological characteristics of patients, their first degree relatives, and culturally appropriate controls. We propose to expand the sample. With the funds of this award we will focus on the clinical characterization of the probands and their siblings as well as of controls and their siblings to investigate the heritability of a composite endophenotype including parkinsonism, smoking, cognitive deficit and hyperechogenicity of the substantia nigra. Towards the end of the award period we will work on an Roi application to study the relationship of the proposed phenotype to quantitative trait loci (QTL). The major relevance of the proposed research lies on the possibility of testing if a neurobiologically well defined set of individual characteristics is genetically determined. Because these deficits possibly predate the onset of psychosis, we believe our strategy might provide tools for early detection and early intervention, possibly leading to prevention of psychosis in subjects at-risk for schizophrenia. Lastly, we anticipate that our research strategy may indicate new ways to study and address the increased vulnerability of schizophrenic patients to nicotine dependence.
描述(由申请人提供):候选人是一位接受过神经生物学培训的神经科医生/精神病学家,也是华盛顿大学医学院(WUStL)的精神病学和神经病学助理教授,华盛顿大学医学院是世界领先的精神疾病遗传学和流行病学机构。该候选人的近期目标是在 Cloninger 博士和 Goate 博士的指导下完成流行病学和遗传学硕士学位,以最大限度地利用他目前资助的研究提供的机会。他的长期目标是将他的研究生涯集中在帕金森症和精神分裂症之间关系的基因控制研究上。项目。帕金森症在新诊断且未经治疗的精神分裂症患者中非常普遍;它的存在预示着更容易受到抗精神病药物引起的副作用、治疗依从性降低和结果较差。吸烟与帕金森病呈负相关,而黑质的高回声、执行功能和工作记忆缺陷以及气质和性格清单上的伤害避免增加都与运动障碍呈正相关。这些不同的表型表现与单一的神经生物学机制有关,即多巴胺能功能下降。研究未经治疗的患者可以防止抗精神病药物的作用将噪音引入到此类表型表现中,因此可以将遗传信号与环境噪音(以治疗为代表)分开。我们确定了未经治疗的精神分裂症人群,并收集了试点样本来研究患者、其一级亲属以及文化上适当的对照的临床、神经心理学和神经学特征。我们建议扩大样本。利用该奖项的资金,我们将重点关注先证者及其兄弟姐妹以及对照及其兄弟姐妹的临床特征,以研究复合内表型的遗传力,包括帕金森病、吸烟、认知缺陷和黑质高回声。在奖励期结束时,我们将开展 Roi 应用程序,以研究拟议表型与数量性状基因座 (QTL) 的关系。拟议研究的主要相关性在于测试神经生物学上明确定义的一组个体特征是否是由基因决定的可能性。由于这些缺陷可能早于精神病发作,我们相信我们的策略可能为早期发现和早期干预提供工具,可能有助于预防有精神分裂症风险的受试者的精神病。最后,我们预计我们的研究策略可能会指明研究和解决精神分裂症患者对尼古丁依赖的脆弱性增加的新方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GABRIEL Alejandro DE ERAUSQUIN其他文献
GABRIEL Alejandro DE ERAUSQUIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GABRIEL Alejandro DE ERAUSQUIN', 18)}}的其他基金
Interactions of SARS-CoV-2 infection and genetic variation on the risk of cognitive decline and Alzheimer’s disease in Ancestral and Admixed Populations
SARS-CoV-2 感染和遗传变异的相互作用对祖先和混血人群认知能力下降和阿尔茨海默病风险的影响
- 批准号:
10628505 - 财政年份:2023
- 资助金额:
$ 16.24万 - 项目类别:
South Texas Alzheimer's Disease Center Clinical Core
南德克萨斯阿尔茨海默病中心临床核心
- 批准号:
10270729 - 财政年份:2021
- 资助金额:
$ 16.24万 - 项目类别:
Multidisciplinary Training Program on Neuropsychiatry and Behavioral Disorders in First Nations (NEUFIN)
原住民神经精神病学和行为障碍多学科培训计划 (NEUFIN)
- 批准号:
10302693 - 财政年份:2021
- 资助金额:
$ 16.24万 - 项目类别:
Multidisciplinary Training Program on Neuropsychiatry and Behavioral Disorders in First Nations (NEUFIN)
原住民神经精神病学和行为障碍多学科培训计划 (NEUFIN)
- 批准号:
10483189 - 财政年份:2021
- 资助金额:
$ 16.24万 - 项目类别:
South Texas Alzheimer's Disease Center Clinical Core
南德克萨斯阿尔茨海默病中心临床核心
- 批准号:
10662340 - 财政年份:2021
- 资助金额:
$ 16.24万 - 项目类别:
Multidisciplinary Training Program on Neuropsychiatry and Behavioral Disorders in First Nations (NEUFIN)
原住民神经精神病学和行为障碍多学科培训计划 (NEUFIN)
- 批准号:
10669755 - 财政年份:2021
- 资助金额:
$ 16.24万 - 项目类别:
South Texas Alzheimer's Disease Center Clinical Core
南德克萨斯阿尔茨海默病中心临床核心
- 批准号:
10472665 - 财政年份:2021
- 资助金额:
$ 16.24万 - 项目类别:
相似国自然基金
儿童药品不良反应主动监测中时序处理策略的方法学研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于真实世界医疗大数据的中西药联用严重不良反应监测与评价关键方法研究
- 批准号:82274368
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于隐狄利克雷分配模型的心血管系统药物不良反应主动监测研究
- 批准号:82273739
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于真实世界数据的创新药品上市后严重罕见不良反应评价关键方法研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
OR10G7错义突变激活NLRP3炎症小体致伊马替尼严重皮肤不良反应的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
Executive functions in urban Hispanic/Latino youth: exposure to mixture of arsenic and pesticides during childhood
城市西班牙裔/拉丁裔青年的执行功能:童年时期接触砷和农药的混合物
- 批准号:
10751106 - 财政年份:2024
- 资助金额:
$ 16.24万 - 项目类别:
Developing and Evaluating a Positive Valence Treatment for Alcohol Use Disorder with Anxiety or Depression
开发和评估治疗伴有焦虑或抑郁的酒精使用障碍的正价疗法
- 批准号:
10596013 - 财政年份:2023
- 资助金额:
$ 16.24万 - 项目类别:
Nursing homes' visitation bans during the COVID-19 pandemic: Effectiveness and consequences.
COVID-19 大流行期间疗养院的探视禁令:有效性和后果。
- 批准号:
10635829 - 财政年份:2023
- 资助金额:
$ 16.24万 - 项目类别:
Targeting Alcohol-Opioid Co-Use Among Young Adults Using a Novel MHealth Intervention
使用新型 MHealth 干预措施针对年轻人中酒精与阿片类药物的同时使用
- 批准号:
10456380 - 财政年份:2023
- 资助金额:
$ 16.24万 - 项目类别:
Development of a digital therapeutic targeting anxiety sensitivity to reduce PTSD-SUD in women presenting for emergency care after sexual assault.
开发一种针对焦虑敏感性的数字疗法,以减少性侵犯后寻求紧急护理的女性的 PTSD-SUD。
- 批准号:
10449766 - 财政年份:2023
- 资助金额:
$ 16.24万 - 项目类别: